Verastem, Inc. 0LOV.L
0LOV.L
Verastem, Inc. 0IGA.L
Emergent BioSolutions Inc. 0HFR.L
Anavex Life Sciences Corp. 0IIM.L
Esperion Therapeutics, Inc. 0UNL.L
Nektar Therapeutics 0IFK.L
Editas Medicine, Inc. 0H7R.L
Abeona Therapeutics Inc. 0IV3.L
Geron Corporation 0JDK.L
Iovance Biotherapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc.
Verastem, Inc. 0IGA.L
Emergent BioSolutions Inc. 0HFR.L
Anavex Life Sciences Corp. 0IIM.L
Esperion Therapeutics, Inc. 0UNL.L
Nektar Therapeutics 0IFK.L
Editas Medicine, Inc. 0H7R.L
Abeona Therapeutics Inc. 0IV3.L
Geron Corporation 0JDK.L
Iovance Biotherapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc.
Performance
| Periode | 0LOV.L | 0IGA.L | 0HFR.L | 0IIM.L | 0UNL.L | 0IFK.L | 0H7R.L | 0IV3.L | 0JDK.L | 0H8T.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 94.17 % | 120.16 % | 8.76 % | 151.40 % | 125.92 % | 204.72 % | 19.93 % | 3.88 % | -36.34 % | 62.33 % |
| YTD | 39.90 % | -5.42 % | -18.99 % | 8.81 % | 5 389.68 % | 182.48 % | -7.61 % | -63.09 % | -74.28 % | -25.87 % |
| 1Y | 187.71 % | 7.93 % | 77.19 % | 26.02 % | 4 052.20 % | 22.47 % | -15.50 % | -67.79 % | -79.19 % | 55.62 % |
| 3Y | 73.90 % | -52.85 % | -10.79 % | -69.03 % | 1 465.97 % | -66.70 % | 10.06 % | -40.18 % | -77.34 % | -88.54 % |
| 5Y | -70.90 % | -90.18 % | -47.05 % | -43.76 % | 263.94 % | -80.52 % | -86.63 % | -22.54 % | -91.51 % | -73.37 % |
| 10Y | -78.77 % | -81.49 % | -47.05 % | -43.76 % | 263.94 % | -80.52 % | -98.61 % | -33.66 % | -91.51 % | -92.32 % |
| From the beginning | -78.77 % | -81.49 % | -47.05 % | -43.76 % | 263.94 % | -80.52 % | -98.61 % | -33.66 % | -91.51 % | -92.32 % |